Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AWKNF

Recent news which mentions AWKNF

< Previous 1 2 3 Next >
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
Tickers AWKNF NEWS
Tags AWKNF Awakn Market News
From Benzinga
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
Tickers AWKNF NEWS
Tags Benzinga Awakn AWKNF
From Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Tickers AWKNF BETRF CMND FLHLF
Tags Psychedelics HUGE BETRF
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Tickers ATAI AWKNF CMND CYBN
Tags Market News Management Psychedelic Research
From Benzinga
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Tickers AWKNF CMND CMPS FLHLF
Tags Global Stories That Matter Legal
From Benzinga
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Tickers ATAI AWKNF CMND CMPS
Tags DRUG CMND ENVB
From Benzinga
Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation
Tickers AWKNF
Tags clinical trial contributors Ketamine
From Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
Tickers ATAI AWKNF CMPS CYBN
Tags SILO AWKNF Market News
From Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
Tickers AWKNF CMPS
Tags Ketamine/Assisted Therapy Psychedelic/Assisted Therapies AWKNF
From Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
Tickers AWKNF
Tags Psychedelics ScholarGPS Psychedelic Science 2023 Conference
From Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Tickers ATAI AWKNF CMND CMPS
Tags CMPS Small Cap Markets
From Benzinga
Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial
Tickers AWKNF
Tags Cannabis Markets Benzinga
From Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Tickers AGNPF ATAI AWKNF CMPS
Tags Market News Management Earnings
From Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
Tickers ATAI AWKNF CMPS CYBN
Tags ATAI Legal DMTTF
From Benzinga
Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics
Tickers AWKNF
Tags Penny Stocks severe alcohol use disorder Psychedelics
From Benzinga
Awakn Life Sciences On Track With Phase 3 Trial To Research Substance Use Disorder
Tickers AWKNF
Tags Markets Benzinga AWKNF
From Benzinga
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
Tickers AWKNF CMPS DMTTF FLHLF
Tags HLCO CMPS Small Cap
From Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
Tickers AWKNF
Tags alcohol use disorder Penny Stocks Psychedelics
From Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
Tickers AWKNF
Tags News Financing Market News
From Benzinga
Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism
Tickers AWKNF
Tags Cannabis Benzinga Markets
From Benzinga
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
Tickers AWKNF IXHL MNMD MSSTF
Tags Psychedelics PSIL MYCOF
From Benzinga
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
Tickers AWKNF
Tags Earnings Ketamine/Assisted Therapy AWKNF
From Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
Tickers AWKNF CMND DRUG HUGE
Tags NMLSF AWKNF Top Stories
From Benzinga
Severe Alcohol Use Disorder Patients Will Try Ketamine Therapy At Awakn's New Phase 3 Study
Tickers AWKNF
Tags Management News Financing
From Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
Tickers AWKNF
Tags Market News Management AWKNF
From Benzinga
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
Tickers ATAI AWKNF CYBN FLHLF
Tags NUMIF Psychedelic/Assisted Therapies Financing
From Benzinga
Awakn's Psychedelics Medical Chief Steps Down, Shifts In Company's Stocks And Ownership
Tickers AWKNF
Tags Cannabis Markets Benzinga
From Benzinga
EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
Tickers AWKNF
Tags AWKNF Ketamine/Assisted Therapy Market News
From Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
Tickers ATAI AWKNF CYBN DMTTF
Tags Benzinga Psychedelics Capital Conference Cannabis MNMD
From Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Tickers AGNPF AWKNF BRAXF CMPS
Tags FTHWF AGNPF Legal
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.